Fresenius Medical Care AG & Co. KGaA (FMCQF)
USD 46.12
(-2.91%)
USD 46.12
(-2.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.92 Billion EUR | -13.33% |
| 2022 | 5.68 Billion EUR | -1.52% |
| 2021 | 5.77 Billion EUR | -14.94% |
| 2020 | 6.78 Billion EUR | 12.09% |
| 2019 | 6.05 Billion EUR | 17.37% |
| 2018 | 5.15 Billion EUR | -14.33% |
| 2017 | 6.01 Billion EUR | 7.19% |
| 2016 | 5.61 Billion EUR | 7.18% |
| 2015 | 5.23 Billion EUR | 27.54% |
| 2014 | 4.1 Billion EUR | 19.73% |
| 2013 | 3.43 Billion EUR | -1.37% |
| 2012 | 3.47 Billion EUR | -0.25% |
| 2011 | 3.48 Billion EUR | 11.92% |
| 2010 | 3.11 Billion EUR | 16.53% |
| 2009 | 2.67 Billion EUR | 2.59% |
| 2008 | 2.6 Billion EUR | 13.26% |
| 2007 | 2.3 Billion EUR | 5.57% |
| 2006 | 2.18 Billion EUR | 10.7% |
| 2005 | 1.96 Billion EUR | 28.0% |
| 2004 | 1.53 Billion EUR | 5.96% |
| 2003 | 1.45 Billion EUR | -7.98% |
| 2002 | 1.57 Billion EUR | -14.34% |
| 2001 | 1.84 Billion EUR | 17.96% |
| 2000 | 1.56 Billion EUR | -7.56% |
| 1999 | 1.68 Billion EUR | 25.48% |
| 1998 | 1.34 Billion EUR | -54.53% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.16 Billion EUR | -0.65% |
| 2024 Q1 | 1.17 Billion EUR | -13.03% |
| 2023 Q3 | 1.29 Billion USD | -0.51% |
| 2023 Q1 | 1.24 Billion USD | -13.67% |
| 2023 Q2 | 1.3 Billion USD | 4.85% |
| 2023 Q4 | 1.49 Billion EUR | 14.69% |
| 2023 FY | 4.92 Billion EUR | -13.33% |
| 2022 FY | 5.68 Billion EUR | -1.52% |
| 2022 Q4 | 1.44 Billion EUR | 8.35% |
| 2022 Q3 | 1.33 Billion EUR | -1.08% |
| 2022 Q2 | 1.34 Billion EUR | 6.99% |
| 2022 Q1 | 1.25 Billion EUR | -4.62% |
| 2021 Q1 | 1.41 Billion EUR | 5.15% |
| 2021 Q4 | 1.31 Billion EUR | 4.09% |
| 2021 Q3 | 1.26 Billion EUR | -1.31% |
| 2021 Q2 | 1.28 Billion EUR | -9.46% |
| 2021 FY | 5.77 Billion EUR | -14.94% |
| 2020 Q1 | 1.41 Billion EUR | -2.95% |
| 2020 Q3 | 1.36 Billion EUR | -4.8% |
| 2020 Q4 | 1.34 Billion EUR | -1.34% |
| 2020 FY | 6.78 Billion EUR | 12.09% |
| 2020 Q2 | 1.43 Billion EUR | 1.79% |
| 2019 FY | 6.05 Billion EUR | 17.37% |
| 2019 Q3 | 1.34 Billion EUR | 1.13% |
| 2019 Q4 | 1.45 Billion EUR | 8.0% |
| 2019 Q2 | 1.33 Billion EUR | 5.19% |
| 2019 Q1 | 1.26 Billion EUR | -8.34% |
| 2018 Q4 | 1.38 Billion EUR | 8.92% |
| 2018 Q1 | 1.2 Billion EUR | -19.41% |
| 2018 Q2 | 1.3 Billion EUR | 8.42% |
| 2018 Q3 | 1.26 Billion EUR | -2.83% |
| 2018 FY | 5.15 Billion EUR | -14.33% |
| 2017 Q3 | 1.42 Billion EUR | -4.73% |
| 2017 FY | 6.01 Billion EUR | 7.19% |
| 2017 Q1 | 1.59 Billion EUR | -9.7% |
| 2017 Q2 | 1.49 Billion EUR | -6.07% |
| 2017 Q4 | 1.49 Billion EUR | 4.82% |
| 2016 FY | 5.61 Billion EUR | 7.18% |
| 2016 Q3 | 1.31 Billion EUR | 4.33% |
| 2016 Q1 | 1.16 Billion EUR | -19.43% |
| 2016 Q4 | 1.76 Billion EUR | 34.37% |
| 2016 Q2 | 1.25 Billion EUR | 8.14% |
| 2015 Q1 | 1.09 Billion EUR | -14.96% |
| 2015 FY | 5.23 Billion EUR | 27.54% |
| 2015 Q4 | 1.44 Billion EUR | 17.5% |
| 2015 Q3 | 1.22 Billion EUR | 6.17% |
| 2015 Q2 | 1.15 Billion EUR | 5.78% |
| 2014 Q3 | 1.01 Billion EUR | 14.32% |
| 2014 FY | 4.1 Billion EUR | 19.73% |
| 2014 Q4 | 1.28 Billion EUR | 26.66% |
| 2014 Q2 | 887.94 Million EUR | 12.85% |
| 2014 Q1 | 786.81 Million EUR | -11.03% |
| 2013 Q4 | 884.37 Million EUR | 2.07% |
| 2013 FY | 3.43 Billion EUR | -1.37% |
| 2013 Q3 | 866.4 Million EUR | -2.69% |
| 2013 Q2 | 890.37 Million EUR | 2.77% |
| 2013 Q1 | 866.4 Million EUR | -3.98% |
| 2012 Q2 | 890.1 Million EUR | 11.02% |
| 2012 Q4 | 902.34 Million EUR | 4.16% |
| 2012 Q3 | 866.27 Million EUR | -2.68% |
| 2012 Q1 | 801.73 Million EUR | -23.66% |
| 2012 FY | 3.47 Billion EUR | -0.25% |
| 2011 Q1 | 733.11 Million EUR | -17.88% |
| 2011 Q4 | 1.05 Billion EUR | 23.62% |
| 2011 Q2 | 774.97 Million EUR | 5.71% |
| 2011 Q3 | 849.54 Million EUR | 9.62% |
| 2011 FY | 3.48 Billion EUR | 11.92% |
| 2010 FY | 3.11 Billion EUR | 16.53% |
| 2010 Q1 | 718.29 Million EUR | -8.02% |
| 2010 Q4 | 892.78 Million EUR | 15.38% |
| 2010 Q3 | 773.75 Million EUR | -6.8% |
| 2010 Q2 | 830.2 Million EUR | 15.58% |
| 2009 Q2 | 664.08 Million EUR | 2.17% |
| 2009 Q1 | 649.96 Million EUR | -7.13% |
| 2009 FY | 2.67 Billion EUR | 2.59% |
| 2009 Q4 | 780.88 Million EUR | 16.86% |
| 2009 Q3 | 668.21 Million EUR | 0.62% |
| 2008 Q2 | 587.08 Million EUR | 8.4% |
| 2008 FY | 2.6 Billion EUR | 13.26% |
| 2008 Q1 | 541.56 Million EUR | -6.3% |
| 2008 Q3 | 644.99 Million EUR | 9.86% |
| 2008 Q4 | 699.82 Million EUR | 8.5% |
| 2007 Q4 | 577.96 Million EUR | -1.57% |
| 2007 Q2 | 618.63 Million EUR | 5.37% |
| 2007 FY | 2.3 Billion EUR | 5.57% |
| 2007 Q1 | 587.13 Million EUR | 5.11% |
| 2007 Q3 | 587.2 Million EUR | -5.08% |
| 2006 Q1 | 477.09 Million EUR | -11.82% |
| 2006 Q4 | 558.59 Million EUR | -5.57% |
| 2006 Q3 | 591.57 Million EUR | 3.68% |
| 2006 FY | 2.18 Billion EUR | 10.7% |
| 2006 Q2 | 570.55 Million EUR | 19.59% |
| 2005 FY | 1.96 Billion EUR | 28.0% |
| 2005 Q4 | 541.04 Million EUR | 9.85% |
| 2005 Q1 | 415.77 Million EUR | 32.85% |
| 2005 Q3 | 492.53 Million EUR | 1.59% |
| 2005 Q2 | 484.83 Million EUR | 16.61% |
| 2004 Q2 | 430.53 Million EUR | 10.06% |
| 2004 FY | 1.53 Billion EUR | 5.96% |
| 2004 Q4 | 312.97 Million EUR | -24.74% |
| 2004 Q1 | 391.18 Million EUR | 23.34% |
| 2004 Q3 | 415.85 Million EUR | -3.41% |
| 2003 Q1 | 381.61 Million EUR | 6.43% |
| 2003 Q3 | 397.55 Million EUR | 3.31% |
| 2003 FY | 1.45 Billion EUR | -7.98% |
| 2003 Q4 | 317.14 Million EUR | -20.23% |
| 2003 Q2 | 384.8 Million EUR | 0.84% |
| 2002 FY | 1.57 Billion EUR | -14.34% |
| 2002 Q3 | 424.87 Million EUR | 3.6% |
| 2002 Q2 | 410.12 Million EUR | -5.26% |
| 2002 Q1 | 432.9 Million EUR | -14.7% |
| 2002 Q4 | 358.57 Million EUR | -15.6% |
| 2001 Q4 | 507.5 Million EUR | 11.12% |
| 2001 Q2 | 482.52 Million EUR | 8.44% |
| 2001 FY | 1.84 Billion EUR | 17.96% |
| 2001 Q1 | 444.95 Million EUR | 485.49% |
| 2001 Q3 | 456.69 Million EUR | -5.35% |
| 2000 Q1 | 442.94 Million EUR | -60.55% |
| 2000 Q4 | 75.99 Million EUR | -88.7% |
| 2000 Q3 | 672.35 Million EUR | 75.62% |
| 2000 Q2 | 382.85 Million EUR | -13.57% |
| 2000 FY | 1.56 Billion EUR | -7.56% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 FY | 1.68 Billion EUR | 25.48% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q1 | 891.88 Million EUR | 11.96% |
| 1999 Q4 | 1.12 Billion EUR | 25.02% |
| 1998 Q4 | 796.62 Million EUR | 5.45% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | 1.34 Billion EUR | -54.53% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | 2.96 Billion EUR | 0.0% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | -52302.81% |
| Arem Pacific Corporation | 239.16 Thousand USD | -2059013.488% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | -691245.09% |
| BioCorRx Inc. | 53.17 Thousand USD | -9261225.084% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | -497397.871% |
| Banyan Corp. | 5 Million USD | -98319.706% |
| Clearday, Inc. | -6.84 Million USD | 71996.449% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -151692.758% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -448667186.195% |
| Empower Clinics Inc. | 1.96 Million USD | -250131.679% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 40379052.115% |
| Selectis Health, Inc. | 5.4 Million USD | -90976.424% |
| Ethema Health Corporation | 4.66 Million USD | -105378.452% |
| HealthLynked Corp. | 2.34 Million USD | -209568.715% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | -72485.276% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | -1019381.794% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | -3327.065% |
| MedSmart Group Inc. | -19.03 Thousand USD | 25867402.238% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -6722375.975% |
| Nova Leap Health Corp. | 9.76 Million USD | -50313.866% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -1400279.625% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -46793.593% |
| Raffles Medical Group Ltd | 239.4 Million USD | -1957.012% |
| Ryman Healthcare Limited | 260.65 Million USD | -1789.347% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 406669.435% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 8044625.214% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 24623185.0% |
| Veltex Corporation | 694.58 Thousand USD | -708900.325% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -1674273.464% |